Fiscal year

NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023

Retrieved on: 
Tuesday, February 14, 2023

“We plan on leveraging our PATrOL™ platform to perform ‘nuclease free’ in vivo gene editing to restore healthy gene function.

Key Points: 
  • “We plan on leveraging our PATrOL™ platform to perform ‘nuclease free’ in vivo gene editing to restore healthy gene function.
  • This technology complements the field of CRISPR/Cas editors, base editors, and prime editors, with the potential to address the majority of disease-causing mutations.
  • We believe the high fidelity and lack of immunogenicity of our editing approach offer the possibility to address tissue turnover by redosing.
  • Throughout calendar year 2023, we anticipate sharing data on ex vivo and in vivo editing results against high-value genetic mutations, together with associated performance metrics, such as fidelity and efficiency.

Great Elm Group Reports Fiscal 2023 Second Quarter Financial Results

Retrieved on: 
Monday, February 13, 2023

WALTHAM, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” or “Great Elm”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal second quarter ended December 31, 2022.

Key Points: 
  • WALTHAM, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” or “Great Elm”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal second quarter ended December 31, 2022.
  • On January 3, 2023, GEG sold its Durable Medical Equipment (“DME”) business for $80 million.
  • GEG retained approximately $154 million of net operating loss (NOL) carryforwards for federal income tax purposes, approximately $131 million of which can be used for certain taxable income in fiscal year 2023 but expire on June 30, 2023.
  • GEG recognized Adjusted EBITDA of ($1.2) million for the second quarter, approximately unchanged from the same period in the prior fiscal year.

Park City Group Revenue Increases 9%, Net Income Increases 45%, EPS Up 62% for Fiscal Second Quarter of 2023

Retrieved on: 
Tuesday, February 14, 2023

Second quarter total revenue increased 9% to $4.75 million from $4.35 million.

Key Points: 
  • Second quarter total revenue increased 9% to $4.75 million from $4.35 million.
  • Quarterly GAAP net income increased 45% to $1.27 million from $0.87 million last year.
  • Quarterly net income to common shareholders was $1.12 million, up 54% from $0.72 million last year.
  • During the quarter, the Company repurchased 88,741 shares at an average price of $5.05 for a total of $448,266 during the quarter.

Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2023

Retrieved on: 
Thursday, February 9, 2023

GARDEN CITY, N.Y., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced financial results for its third fiscal quarter ended December 31, 2022.

Key Points: 
  • “We are successfully executing on our planned limited launch of LungFit PH in the United States.
  • General and administrative expenses for the fiscal quarter ended December 31, 2022 increased to $8.9 million, compared with $4.9 million for the fiscal quarter ended December 31, 2021.
  • As of December 31, 2022, the Company reported cash and cash equivalents, marketable securities, and restricted cash of $63.2 million.
  • Through the first nine months of the Company’s fiscal year 2023, total cash burn was $27.0 million which includes $2.5 million in non-recurring expense.

Persistent Announces Another Quarter of Consistent Growth with Revenue Up 32.8%

Retrieved on: 
Wednesday, January 18, 2023

SANTA CLARA, Calif. and PUNE, India, Jan. 18, 2023 /PRNewswire/ -- 

Key Points: 
  • Sandeep Kalra, Chief Executive Officer and Executive Director, Persistent:
    "We are delighted to announce the 11th sequential quarter of revenue growth, fueled by our continued investments in innovative technologies and our differentiated Digital Engineering expertise.
  • In this dynamic macro-economic environment, we are closely collaborating with our clients and partner ecosystem to create competitive advantage and drive business value.
  • As a result, we won several large deals across industries and service lines, driving 20% sequential growth in total contract value (TCV) bookings.
  • Revamping existing applications to improve customer experience and scaling business growth for one of the leading banks.

Persistent Announces Another Quarter of Consistent Growth with Revenue Up 32.8%

Retrieved on: 
Wednesday, January 18, 2023

SANTA CLARA, Calif. and PUNE, India, Jan. 18, 2023 /PRNewswire/ -- 

Key Points: 
  • Sandeep Kalra, Chief Executive Officer and Executive Director, Persistent:
    "We are delighted to announce the 11th sequential quarter of revenue growth, fueled by our continued investments in innovative technologies and our differentiated Digital Engineering expertise.
  • In this dynamic macro-economic environment, we are closely collaborating with our clients and partner ecosystem to create competitive advantage and drive business value.
  • As a result, we won several large deals across industries and service lines, driving 20% sequential growth in total contract value (TCV) bookings.
  • Revamping existing applications to improve customer experience and scaling business growth for one of the leading banks.

Monster Beverage Announces Auditor Change

Retrieved on: 
Friday, January 13, 2023

CORONA, Calif., Jan. 13, 2023 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that, as a result of a review process, the Audit Committee of its Board of Directors has approved the engagement of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023, subject to the execution of an engagement letter. Deloitte & Touche LLP (“Deloitte”), the Company’s current independent registered public accounting firm, will continue as the Company’s independent registered public accounting firm for the year ended December 31, 2022. The review process was not related to any disagreement between the Company and Deloitte.

Key Points: 
  • Deloitte & Touche LLP (“Deloitte”), the Company’s current independent registered public accounting firm, will continue as the Company’s independent registered public accounting firm for the year ended December 31, 2022.
  • The review process was not related to any disagreement between the Company and Deloitte.
  • Based in Corona, California, Monster Beverage Corporation is a holding company and conducts no operating business except through its consolidated subsidiaries.
  • The Company’s subsidiaries develop and market energy drinks, including Monster Energy® energy drinks, Monster Energy Ultra® energy drinks, Juice Monster® Energy + Juice energy drinks, Java Monster® non-carbonated coffee + energy drinks, Espresso Monster® non-carbonated espresso + energy drinks, Rehab® Monster® non-carbonated energy drinks, Monster Hydro® Energy Water non-carbonated refreshment + energy drinks, Monster Hydro Super Sport® Superior Hydration non-carbonated refreshment + energy drinks, Monster HydroSport Super Fuel® non-carbonated advanced hydration + energy drinks, Monster Dragon Iced Tea® non-carbonated energy teas, Muscle Monster® non-carbonated energy shakes, Monster Energy® Nitro energy drinks, Reign Total Body Fuel® high performance energy drinks, Reign Inferno® thermogenic fuel high performance energy drinks, True North® Pure Energy Seltzer energy drinks, NOS® energy drinks, Full Throttle® energy drinks, Burn® energy drinks, Samurai® energy drinks, Relentless® energy drinks, Mother® energy drinks, Play® and Power Play® (stylized) energy drinks, BU® energy drinks, Nalu® energy drinks, BPM® energy drinks, Gladiator® energy drinks, Ultra Energy® energy drinks, Live+® energy drinks, Predator® energy drinks and Fury® energy drinks.

AHF Thanks U.S. for Boosting Global Health Funding

Retrieved on: 
Friday, December 23, 2022

AIDS Healthcare Foundation (AHF) applauded the U.S. Congress today for approving an increase in global health appropriations, including funding for HIV/AIDS and TB programs, as part of the Fiscal Year (FY) 2023 Omnibus Appropriations Bill.

Key Points: 
  • AIDS Healthcare Foundation (AHF) applauded the U.S. Congress today for approving an increase in global health appropriations, including funding for HIV/AIDS and TB programs, as part of the Fiscal Year (FY) 2023 Omnibus Appropriations Bill.
  • Congress appropriated $11.2 billion for global health in its year-end spending package, including $4.7 billion for bilateral HIV/AIDS programs and $2 billion for the Global Fund to Fight AIDS, Tuberculosis and Malaria.
  • “We thank the U.S. government for its continued strong commitment to global health, and especially for supporting the President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
  • “We hope that the actions by the U.S. will spur other countries, particularly our G7 partners, to follow this example and invest more in global health so that the world can be better protected against future health crises.”
    AHF has advocated for increased global public health funding since the early days of the COVID-19 pandemic.

IHT FISCAL FIRST THREE QUARTERS PROFIT UP 87%; UNIGEN DESIGN COMPLETE

Retrieved on: 
Wednesday, December 14, 2022

Total Consolidated Net Income for the First Three Fiscal Quarters increased 87% to approximately $730,000, from the prior year’s First Three Fiscal Quarters of $391,153.

Key Points: 
  • Total Consolidated Net Income for the First Three Fiscal Quarters increased 87% to approximately $730,000, from the prior year’s First Three Fiscal Quarters of $391,153.
  • Earnings Per Share based on this First Fiscal Three Quarters Consolidated Net Income was $0.04 per share, up $0.09 from the prior First Fiscal Three Quarters of last year of ($0.05), an all-time First Fiscal Three Quarter recovery.
  • Net Income before non-cash depreciation expense was $1,259,734 for the Fiscal First Three Quarters ended October 31, 2022, up approximately 30%, or $291,037, compared to prior Year Fiscal First Three Quarters ended October 31, 2022.
  • UniGen has confirmed that the major design work for the UPI 1000 NG engine is now complete.